We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+14.12%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
10 Year Est. Return
AUM
$140M
AUM Growth
+$6.35M
Cap. Flow
-$8.1M
Cap. Flow %
-5.79%
Top 10 Hldgs %
21.84%
Holding
399
New
39
Increased
29
Reduced
77
Closed
121

Top Buys

Rank Stock Value
1
KNF icon
Knife River
KNF
+$1.15M
2
COR icon
Cencora
COR
+$1M
3
MSFT icon
Microsoft
MSFT
+$899K
4
HWC icon
Hancock Whitney
HWC
+$889K
5
RNG icon
RingCentral
RNG
+$842K

Top Sells

Rank Stock Value
1
COKE icon
Coca-Cola Consolidated
COKE
+$1.33M
2
JKS
JinkoSolar
JKS
+$1.11M
3
PDD icon
Pinduoduo
PDD
+$1.05M
4
LEA icon
Lear
LEA
+$1.04M
5
BZH icon
Beazer Homes USA
BZH
+$764K

Sector Composition

Rank Sector Weight
1 Technology 18.76%
2 Healthcare 15.09%
3 Consumer Discretionary 12.85%
4 Industrials 12.39%
5 Financials 11.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRA icon
26
Strategic Education
STRA
$1.92B
$1.1M 0.78%
10,534
HNI icon
27
HNI Corp
HNI
$3.59B
$1.08M 0.77%
24,000
COR icon
28
Cencora
COR
$61.2B
$1.06M 0.76%
+4,362
New +$1M
DOCU
29
DocuSign
DOCU
$11.5B
$1.05M 0.75%
17,670
+5,523
+45% +$312K
NMIH icon
30
NMI Holdings
NMIH
$3.36B
$1.04M 0.74%
32,106
+1,410
+5% +$42.6K
ADMA icon
31
ADMA Biologics
ADMA
$2.22B
$1.04M 0.74%
157,268
AMWD
32
DELISTED
American Woodmark
AMWD
$1.02M 0.73%
10,076
SUPN icon
33
Supernus Pharmaceuticals
SUPN
$2.77B
$994K 0.71%
29,148
MANH icon
34
Manhattan Associates
MANH
$11.4B
$981K 0.7%
3,919
+400
+11% +$95.2K
FIX icon
35
Comfort Systems
FIX
$59.6B
$967K 0.69%
3,045
EME icon
36
Emcor
EME
$36B
$947K 0.68%
2,704
+730
+37% +$196K
HWC icon
37
Hancock Whitney
HWC
$6.24B
$921K 0.66%
+20,014
New +$889K
PHM icon
38
Pultegroup
PHM
$25.3B
$918K 0.66%
7,614
-572
-7% -$61.4K
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.33T
$875K 0.63%
5,795
+2,631
+83% +$376K
RNG icon
40
RingCentral
RNG
$5.28B
$869K 0.62%
+25,000
New +$842K
ANIP icon
41
ANI Pharmaceuticals
ANIP
$1.78B
$852K 0.61%
12,319
THR
42
DELISTED
Thermon Group Holdings
THR
$838K 0.6%
25,598
AAL icon
43
American Airlines Group
AAL
$10.6B
$837K 0.6%
+54,556
New +$791K
CI icon
44
Cigna
CI
$74.6B
$834K 0.6%
2,296
-693
-23% -$228K
MRK icon
45
Merck
MRK
$318B
$805K 0.58%
6,099
+1,618
+36% +$199K
UFPI icon
46
UFP Industries
UFPI
$5.19B
$796K 0.57%
6,467
WNC icon
47
Wabash National
WNC
$527M
$791K 0.57%
26,424
XRX icon
48
Xerox
XRX
$425M
$786K 0.56%
+43,907
New +$772K
DECK icon
49
Deckers Outdoor
DECK
$13.3B
$752K 0.54%
4,794
-276
-5% -$38.3K
IBM icon
50
IBM
IBM
$224B
$745K 0.53%
3,899
-254
-6% -$46.3K

Similar funds

Virtus Investment Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus Investment Advisers held 399 positions worth $140M, up 4.8% from $134M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Virtus Investment Advisers withdrew a net $8.1M in Q1 2024, closing 121 positions and reducing 77 holdings. Its most notable exit was JinkoSolar, an estimated $1.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Virtus Investment Advisers opened a new position in Cencora worth $1.06M.

  • Virtus Investment Advisers's largest Q1 2024 buy was Cencora: 4,362 shares worth $1.06M.
  • Virtus Investment Advisers added most to Knife River in Q1 2024, an estimated $1.15M increase.
  • Virtus Investment Advisers's biggest Q1 2024 reduction was Coca-Cola Consolidated, cutting an estimated $1.33M.
  • Virtus Investment Advisers fully exited JinkoSolar in Q1 2024, selling an estimated $1.11M.
  • Virtus Investment Advisers's ten largest holdings make up 22% of its $140M portfolio in Q1 2024.
  • Virtus Investment Advisers opened 39 new positions and closed 121 in Q1 2024.
  • Virtus Investment Advisers's portfolio value rose 4.8% quarter-over-quarter to $140M.

Based on Virtus Investment Advisers's 13F filing for Q1 2024, filed 16 May 2024.